HLA-DQ7
major histocompatibility complex, class II, DQ7 | |
Haplotypes | DQA1*03:02:DQB1*03:01 DQA1*03:03:DQB1*03:01 DQA1*04:01:DQB1*03:01 DQA1*05:05:DQB1*03:01 DQA1*06:01:DQB1*03:01 |
Structure (See HLA-DQ) | |
Identifiers | alpha 1 *0302 *0303 *0401 *0505 *0601 |
Symbol(s) | HLA-DQA1 |
EBI-HLA | DQA1*0302 |
EBI-HLA | DQA1*0303 |
EBI-HLA | DQA1*0401 |
EBI-HLA | DQA1*0505 |
EBI-HLA | DQA1*0601 |
Identifiers | beta 1 *0301 *0304 |
Symbol(s) | HLA-DQB1 |
EBI-HLA | DQB1*0301 |
EBI-HLA | DQB1*0304 |
Shared data | |
Locus | chr.6 6p21.31 |
HLA-DQ7 (DQ7) is an HLA-DQ serotype that recognizes the common HLA DQB1*0301[1] and the less common HLA DQB1*0304 gene products. DQ7 is a form of 'split antigen' of the broad antigen group DQ3 which also contains DQ8 and DQ9.
DQ7 is linked by haplotype to a number of DQA1 (DQ alpha chain) genes, producing in cis-haplotype form, a large number of DQ αβ isoforms. These DQ alpha chains are also known to form transhaplotype isomers with other HLA-DQ.
DQ7 is linked to the following alpha chains genes (DQA1*)
- 03 - *0301, *0302, *0303
- 0401
- 0505
- 0601
Serology
DQB1* | DQ7 | DQ3 | DQ8 | Sample |
allele | % | % | % | size (N) |
0301 | 85 | 40 | 1 | 12220 |
0304 | 40 | 35 | 8 | 111 |
Serotyping efficiency. The serotyping efficiency of DQ7 toward DQB1*0301 is reasonably good, but still results in some false negatives, for *0304 the typing efficiency is poor and cross-reaction with DQ8 is relatively high.
Alleles
DQB1*0301
DQB1*0301 is the major DQ7 allele DQB1*0301 appears to be associated with lupus anticoagulant.[3]
DQB1*0304
DQB1*0304 is the minor DQ7 allele
Haplotypes
freq | ||
ref. | Population | (%) |
[4] | Chukotka Chukchi (Siberia) | 26.7 |
[4] | Chukotka Eskimos (Siberia) | 25.0 |
[4] | Koryaks (NE Kamchatka, Siberia) | 19.1 |
[4] | Polygus Evenks (Siberia) | 11.4 |
[4] | Khalkh (Ulaanbaatar, Mongolia) | 11.0 |
[4] | Negidal (Siberia) | 9.6 |
[4] | Kushun Buryat (Siberia) | 8.0 |
[4] | Tarialan Khoton (Mongolia) | 7.8 |
[4] | France Ceph | 6.0 |
[4] | Russia Tuva (2) | 6.0 |
[4] | Udegeys Gvaysugi (Siberia) | 4.8 |
[4] | Irkutsk Tofalar (Siberia ) | 4.7 |
[4] | Ulchi (Siberia) | 4.1 |
[4] | Belgian pop2 | 4.1 |
[4] | England Caucasoid | 4.0 |
[4] | Italy pop 2 | 2.8 |
[4] | Russia Tuva Todja | 2.3 |
[4] | China Ürümqi Kazak | 2.4 |
[4] | Sulamai Kets (Siberia) | 2.3 |
[4] | Russia Siberia Nganasan Dudinka | 2.1 |
[4] | NW Slavic Russia | 2.0 |
[4] | Japan Fukuoka | 1.2 |
[4] | Japan (2) | 1.1 |
DQ haplotypes of this serotype are formed between the cis-chromosomal genes of the DQA1 locus. This includes DQA1*0301, *0302, *0303, *0401, *0505, *0601.
There is a rather large degree of disequilibration about DQA1*0301 suggesting that this is one of the older and more established HLA DQB1* alleles in Eurasia. The intron structure of DQB1 suggest that DQB1*0301 DQB1*0302/*0303 split occurred before DQB1*0302/*0303, the distribution of *03 in Africa suggest that recombination DQA1*03:DQB1*0301 are primarily the result of recombination events that have occurred in Africa. A recent study of myasthenia gravis in Houston confirms the presence of A*0505:B*0301 in Nigeria. B1*0301 and A1*03 haplotypes are found at relatively high frequencies in SE Asia and Austronesia, also indicating that it is well established in the exo-African population.
DQ7.3
The DQ7.3 haplotype can be formed by DQA1*0301:DQB1*0301, DQA1*0302:DQB1*0301, DQA1*0303:DQB1*0301. In the west, the DQA1*0303:DQB1*0301 haplotype appears to be more common. The gene products of all 3 function similarly and subunits are interchangeable. In the literature, older DNA tests recognize DQA1*0303 as DQA1*0302, and still oldest DNA tests recognize all three as DQA1*03 or DQA1*0301.
DQA1*0303:DQB1*0301 may be involved in narcolepsy.[5] DQ7.3 appears to be associated with oral ulcerations and gingival disease [6]
DQ7.4
freq | ||
ref. | Population | (%) |
[4] | Chukotka Chukchi (Siberia) | 9.5 |
[4] | Gvaysugi Udegeys (Siberia) | 9.5 |
[4] | Chukotka Eskimos (Siberia) | 8.7 |
[4] | Polygus Evenks (Siberia) | 7.2 |
[4] | NE Koryaks (Kamchatka) | 6.5 |
[4] | Cameroon Saa | 4.4 |
[4] | Sulamai Kets (Siberia) | 2.3 |
[4] | Gambia | 1.4 |
[4] | Fukuoka Japan | 1.2 |
[7] | Caucasian Americans | 0.3 |
DQA1*0401:DQB1*0301 (DQ7.4) This haplotype is found in Siberia, Africa but also at low levels in Western Europe.
DQ7.5
freq | ||
ref. | Population | (%) |
[4] | Lebanon (estimated) | 40.0 |
[4] | Italy Rome | 29.6 |
[4] | Netherlands (2) | 15.5 |
[4] | Tunisia | 14.6 |
[4] | England (2) | 10.1 |
[4] | South Korea | 6.8 |
[4] | Congo Kinshasa Bantu | 4.4 |
DQA1*0505:DQB1*0301 (DQ7.5) was gene-typed as DQA1*0501:DQB1*0301 until it was recognized that there was amino acid sequence variant in the preprocessed DQA1* gene product (proto-α-chain polypeptide encoded DQA1*0505). This proto-alpha, once processed, is identical to the DQA1*0501 encoded α-chain once it is processed. Almost 100% of DQ7.5 haplotypes carry the DQA1*0505 allele.[8] The DR5-DQ7.5 is common in the Southeastern Europe and the Levant, with DQ7.5 reaching a haplotype frequency of 40% in Lebanon. Its high level is probably not by chance, the haplotype appears to protect against juvenile diabetes, which appears to be more common among cereal eating peoples.[9] Cereals were first domesticated in the Near and Middle East more than 10,000 years ago and selection may explain DQ7.5's higher frequencies. (See: Triticeae)
The processed alpha subunit of DQA1*0505 is identical to that of DQA1*0501, but some slight differences in the association with autoimmune disease are observed, possibly as a result of linked DR and DQB1 genes. DQA1*0505 can play into celiac disease under two circumstances. First it can increase risk when DQ2.5 is present, although current studies indicate that it marginally increases risk relative to DQB1*0202 in DQ2.5 cis haplotype. DQA1*0505, without DQ2, is found in a small percentage of coeliac disease (without DQ2 or DQ8).[10]
DQ7.5 is found also high in frequency in the new world, but with DR types less commonly encountered in the old world. DQA1*05 allele is not clear in the new world. DQB1*0301 may be under current positive selection in the human population, at least in areas where DQ2.5 and DQ8 are high, as it confers resistance to type 1 diabetes. For hepatitis type B, DQ7 is associated with persistence but for C, DQ7 is associated with clearance.[11] DQA1*0505, DQB1*0301 appear to increase the risk for melanoma in the Spanish population however this may have a linkage to more recent fair skinned migrants. DQB1*0301 is also associated with allergic fungal sinusitis, human papillomavirus (HPV) induced warts, limited cutaneous systemic sclerosis in Africans, and primary sclerosing cholangitis in Southern Europeans. DQB1*0301 is also predisposing in narcolepsy.[5] DQB1*0301 does not to play a role in any frequently occurring autoimmune disease and its presence in the near east and suppressed frequencies of coeliac disease and Type 1 diabetes in these regions is suggestive that it has a positive selection in Post-Mesolithic cereal based societies in the Western Eurasia.
DQB1*0301 appears to be more associated with early onset myasthenia gravis in Japanese than DQ8, and was also found along with DQB1*0304 to be associated with Chinese MG. DQ7 or associated DR types may play a role in rheumatoid arthritis. In celiac disease the DQ7 (A*0505/1) can mediate celiac disease when HLA DQ2.2 is also present. HLA DQB1*0301 in Turks is associated with Thymoma but the risk may be associated with HLA class I loci.
DQ7.6
freq | ||
ref. | Population | (%) |
[4] | Java Yogyakarta | 48.1 |
[4] | Kiribati | 37.9 |
[4] | Nauru | 28.4 |
[4] | Harbin City (Manchuria, China) | 12.8 |
[4] | Thailand | 12.7 |
[4] | South Korean (5) | 4.4 |
[4] | China Beijing and Xian | 3.5 |
[4] | Japan | 3.0 |
[4] | India Bombay | 1.7 |
[4] | England Caucasoid | 0.6 |
[4] | Italy Central | 0.6 |
[4] | Algeria1 | 0.5 |
[4] | Cameroon | 0.4 |
DQA1*0601:DQB1*0301 (DQ7.6) is a globally rare haplotype, however it is found at high frequencies in the South Pacific and along the West Pacific rim. DQB1*0301 appears to be uniquely linked to DQA1*0601. DQ7.6 is positively associated with asthma,[12] pauciarticular juvenile arthritis without anti-nuclear antibodies,[13] DQ7.6 is negatively associated (Protective against) juvenile diabetes,[14] liver and spleen disease in Schistosoma japonicum infection,[15] pulmonary tuberculosis.[16]
References
- ↑ Bunce M, Taylor CJ, Welsh KI (1993). "Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP)". Hum. Immunol. 37 (4): 201–6. doi:10.1016/0198-8859(93)90502-R. PMID 7905469.
- ↑ derived from IMGT/HLA
- ↑ Arnett FC, Olsen ML, Anderson KL, Reveille JD (1991). "Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant". J. Clin. Invest. 87 (5): 1490–5. doi:10.1172/JCI115158. PMC 295227. PMID 1673688.
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database: http://www.allelefrequencies.net". Tissue Antigens 61 (5): 403–7. doi:10.1034/j.1399-0039.2003.00062.x. PMID 12753660. External link in
|title=
(help) - 1 2 Hong SC, Lin L, Lo B, et al. (2007). "DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans". Hum. Immunol. 68 (1): 59–68. doi:10.1016/j.humimm.2006.10.006. PMID 17207713.
- ↑ "Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.". Proc Natl Acad Sci U S A 91 (16): 7747–51. Aug 1994. doi:10.1073/pnas.91.16.7747. PMID 8052655.
- ↑ Klitz W, Maiers M, Spellman S, et al. (2003). "New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans". Tissue Antigens 62 (4): 296–307. doi:10.1034/j.1399-0039.2003.00103.x. PMID 12974796.
- ↑ Pera C, Delfino L, Longo A, Pistillo MP, Ferrara GB (2000). "Novel associations among HLA-DQA1 and -DQB1 alleles, revealed by high-resolution sequence-based typing (SBT)". Tissue Antigens 55 (3): 275–9. doi:10.1034/j.1399-0039.2000.550313.x. PMID 10777105.
- ↑ Almawi WY, Wakim-Ghorayeb SF, Arekat MR, et al. (2006). "Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon". Clin. Vaccine Immunol. 13 (11): 1296–8. doi:10.1128/CVI.00206-06. PMC 1656545. PMID 16988007.
- ↑ Karell K, Louka AS, Moodie SJ, et al. (2003). "HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease". Hum. Immunol. 64 (4): 469–77. doi:10.1016/S0198-8859(03)00027-2. PMID 12651074.
- ↑ Singh R, Kaul R, Kaul A, Khan K (2007). "A comparative review of HLA associations with hepatitis B and C viral infections across global populations". World J. Gastroenterol. 13 (12): 1770–87. doi:10.3748/wjg.v13.i12.1770. PMID 17465466.
- ↑ Guo X, Ni P, Li L (2001). "[Association between asthma and the polymorphism of HLA-DQ genes]". Zhonghua Jie He He Hu Xi Za Zhi (in Chinese) 24 (3): 139–41. PMID 11802952.
- ↑ Donn RP, Thomson W, Pepper L, et al. (1995). "Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype". Br. J. Rheumatol. 34 (5): 461–5. doi:10.1093/rheumatology/34.5.461. PMID 7788177.
- ↑ Chuang LM, Jou TS, Wu HP, et al. (1995). "HLA DQA1 genotypes and its interaction with HLA DQB1 in Chinese IDDM living in Taiwan". Proc. Natl. Sci. Counc. Repub. China B 19 (2): 73–9. PMID 7624445.
- ↑ Waine GJ, Ross AG, Williams GM, Sleigh AC, McManus DP (1998). "HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum". Int. J. Parasitol. 28 (4): 537–42. doi:10.1016/S0020-7519(98)00020-4. PMID 9602373.
- ↑ Vejbaesya S, Chierakul N, Luangtrakool K, Srinak D, Stephens HA (2002). "Associations of HLA class II alleles with pulmonary tuberculosis in Thais". Eur. J. Immunogenet. 29 (5): 431–4. doi:10.1046/j.1365-2370.2002.00352.x. PMID 12358854.
|